alexa Abstract | Prediction of novel drug targets in Ergosterol biosynthesis pathway: A proposed mechanism of anticandidal activity of green tea phytocompounds

Journal of Chemical and Pharmaceutical Research
Open Access

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Original Articles Open Access


The emergence of antibiotic resistance in pathogenic Candida species has led to explore new alternative therapies to combat its associated life threatening infections. Synergistic anticandidal potentials of green tea (derived from Camellia sinensis) with antifungal agents is well known. Our study aims at predicting the novel inhibitory targets of green tea (GT) phytocompounds and pretending the inhibitory mechanism involved in synergistic inhibition of GT with antifungals. The interaction of GT phytocompounds and ergosterol synthesising proteins (ERG) of the Candida species has been assessed by in silico study using iGEMDOCK software which revealed ERG 26, ERG 6, ERG 25, and ERG 8 proteins as novel drug targets of kaempferitrin, EGCG, ECG, chlorogenic acid respectively present in GT.Supporting our investigation, in vitro studies have been done with GT leaves from different geographical locations. Catechins were purified and identified by HPLC and synergistic effect of solvent extracts and purified catechins with fluconazole (Flu), Amphotericin B (AmB) against Candida albicans and Candida glabrata depicted the convincing synergistic inhibitory effect of GT. The simultaneous interaction of GT and antifungals with ERG proteins could be the prohibitory mechanism that inhibits the growth of Candida species implying the candidacidal synergy between GT and antifungals.

To read the full article Peer-reviewed Article PDF image

Author(s): Jigisha Anand Prabhakar Semwal Pankaj Gautam Ashish Thapliyal and Nishant Rai


Green tea phytocompounds, ERG, antifungal drug, Candida albicans, in silico., novel drug targets

Peer Reviewed Journals
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version